The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
High Content Screening (HCS)-Global Market Insights and Sales Trends 2024
Synopsis
High-content screening (HCS) technology involves imaging-based multi-parametric analysis at the single-cell level. This technology was initially developed to complement biological high throughput screening in drug discovery. HCS analyses phenotypic changes in cellular samples.
The global High Content Screening (HCS) market size is expected to reach US$ 1076.3 million by 2029, growing at a CAGR of 8.3% from 2023 to 2029. The market is mainly driven by the significant applications of High Content Screening (HCS) in various end use industries. The expanding demands from the Primary & Secondary Screening, Toxicity Studies and Target Identification & Validation,, are propelling High Content Screening (HCS) market. Cell Imaging & Analysis System, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Flow Cytometry segment is estimated at % CAGR for the next seven-year period.
Owing to enhanced toxicity studies, demand for novel technologies in cell analysis is increasing rapidly across the globe. Instruments with enhanced cell imaging and analysis are preferred for early as well as later stages of the drug discovery process. This is expected to fuel the demand for High Content Screening (HCS) instruments in the near future. Also, increasing government support for life sciences research and increasing progress towards establishment of innovation and research-based biotechnology industries, primarily in countries such as China and India, is expected to contribute towards increased growth rate during the forecast period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for High Content Screening (HCS), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global High Content Screening (HCS) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global High Content Screening (HCS) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, High Content Screening (HCS) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of High Content Screening (HCS) covered in this report include Becton, Dickinson and Company, GE Healthcare, Danaher, PerkinElmer and Thermo Fisher Scientific, etc.
The global High Content Screening (HCS) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Becton, Dickinson and Company
GE Healthcare
Danaher
PerkinElmer
Thermo Fisher Scientific
Global High Content Screening (HCS) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global High Content Screening (HCS) market, Segment by Type:
Cell Imaging & Analysis System
Flow Cytometry
Consumable
Software
Service
Global High Content Screening (HCS) market, by Application
Primary & Secondary Screening
Toxicity Studies
Target Identification & Validation
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of High Content Screening (HCS) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
High-content screening (HCS) technology involves imaging-based multi-parametric analysis at the single-cell level. This technology was initially developed to complement biological high throughput screening in drug discovery. HCS analyses phenotypic changes in cellular samples.
The global High Content Screening (HCS) market size is expected to reach US$ 1076.3 million by 2029, growing at a CAGR of 8.3% from 2023 to 2029. The market is mainly driven by the significant applications of High Content Screening (HCS) in various end use industries. The expanding demands from the Primary & Secondary Screening, Toxicity Studies and Target Identification & Validation,, are propelling High Content Screening (HCS) market. Cell Imaging & Analysis System, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Flow Cytometry segment is estimated at % CAGR for the next seven-year period.
Owing to enhanced toxicity studies, demand for novel technologies in cell analysis is increasing rapidly across the globe. Instruments with enhanced cell imaging and analysis are preferred for early as well as later stages of the drug discovery process. This is expected to fuel the demand for High Content Screening (HCS) instruments in the near future. Also, increasing government support for life sciences research and increasing progress towards establishment of innovation and research-based biotechnology industries, primarily in countries such as China and India, is expected to contribute towards increased growth rate during the forecast period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for High Content Screening (HCS), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global High Content Screening (HCS) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global High Content Screening (HCS) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, High Content Screening (HCS) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of High Content Screening (HCS) covered in this report include Becton, Dickinson and Company, GE Healthcare, Danaher, PerkinElmer and Thermo Fisher Scientific, etc.
The global High Content Screening (HCS) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Becton, Dickinson and Company
GE Healthcare
Danaher
PerkinElmer
Thermo Fisher Scientific
Global High Content Screening (HCS) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global High Content Screening (HCS) market, Segment by Type:
Cell Imaging & Analysis System
Flow Cytometry
Consumable
Software
Service
Global High Content Screening (HCS) market, by Application
Primary & Secondary Screening
Toxicity Studies
Target Identification & Validation
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of High Content Screening (HCS) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of High Content Screening (HCS)
1.1 High Content Screening (HCS) Market Overview
1.1.1 High Content Screening (HCS) Product Scope
1.1.2 High Content Screening (HCS) Market Status and Outlook
1.2 Global High Content Screening (HCS) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global High Content Screening (HCS) Market Size by Region (2018-2029)
1.4 Global High Content Screening (HCS) Historic Market Size by Region (2018-2023)
1.5 Global High Content Screening (HCS) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, High Content Screening (HCS) Market Size (2018-2029)
1.6.1 North America High Content Screening (HCS) Market Size (2018-2029)
1.6.2 Europe High Content Screening (HCS) Market Size (2018-2029)
1.6.3 Asia-Pacific High Content Screening (HCS) Market Size (2018-2029)
1.6.4 Latin America High Content Screening (HCS) Market Size (2018-2029)
1.6.5 Middle East & Africa High Content Screening (HCS) Market Size (2018-2029)
2 High Content Screening (HCS) Market by Type
2.1 Introduction
2.1.1 Cell Imaging & Analysis System
2.1.2 Flow Cytometry
2.1.3 Consumable
2.1.4 Software
2.1.5 Service
2.2 Global High Content Screening (HCS) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global High Content Screening (HCS) Historic Market Size by Type (2018-2023)
2.2.2 Global High Content Screening (HCS) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America High Content Screening (HCS) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe High Content Screening (HCS) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific High Content Screening (HCS) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America High Content Screening (HCS) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa High Content Screening (HCS) Revenue Breakdown by Type (2018-2029)
3 High Content Screening (HCS) Market Overview by Application
3.1 Introduction
3.1.1 Primary & Secondary Screening
3.1.2 Toxicity Studies
3.1.3 Target Identification & Validation
3.2 Global High Content Screening (HCS) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global High Content Screening (HCS) Historic Market Size by Application (2018-2023)
3.2.2 Global High Content Screening (HCS) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America High Content Screening (HCS) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe High Content Screening (HCS) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific High Content Screening (HCS) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America High Content Screening (HCS) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa High Content Screening (HCS) Revenue Breakdown by Application (2018-2029)
4 High Content Screening (HCS) Competition Analysis by Players
4.1 Global High Content Screening (HCS) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in High Content Screening (HCS) as of 2022)
4.3 Date of Key Players Enter into High Content Screening (HCS) Market
4.4 Global Top Players High Content Screening (HCS) Headquarters and Area Served
4.5 Key Players High Content Screening (HCS) Product Solution and Service
4.6 Competitive Status
4.6.1 High Content Screening (HCS) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Becton, Dickinson and Company
5.1.1 Becton, Dickinson and Company Profile
5.1.2 Becton, Dickinson and Company Main Business
5.1.3 Becton, Dickinson and Company High Content Screening (HCS) Products, Services and Solutions
5.1.4 Becton, Dickinson and Company High Content Screening (HCS) Revenue (US$ Million) & (2018-2023)
5.1.5 Becton, Dickinson and Company Recent Developments
5.2 GE Healthcare
5.2.1 GE Healthcare Profile
5.2.2 GE Healthcare Main Business
5.2.3 GE Healthcare High Content Screening (HCS) Products, Services and Solutions
5.2.4 GE Healthcare High Content Screening (HCS) Revenue (US$ Million) & (2018-2023)
5.2.5 GE Healthcare Recent Developments
5.3 Danaher
5.3.1 Danaher Profile
5.3.2 Danaher Main Business
5.3.3 Danaher High Content Screening (HCS) Products, Services and Solutions
5.3.4 Danaher High Content Screening (HCS) Revenue (US$ Million) & (2018-2023)
5.3.5 PerkinElmer Recent Developments
5.4 PerkinElmer
5.4.1 PerkinElmer Profile
5.4.2 PerkinElmer Main Business
5.4.3 PerkinElmer High Content Screening (HCS) Products, Services and Solutions
5.4.4 PerkinElmer High Content Screening (HCS) Revenue (US$ Million) & (2018-2023)
5.4.5 PerkinElmer Recent Developments
5.5 Thermo Fisher Scientific
5.5.1 Thermo Fisher Scientific Profile
5.5.2 Thermo Fisher Scientific Main Business
5.5.3 Thermo Fisher Scientific High Content Screening (HCS) Products, Services and Solutions
5.5.4 Thermo Fisher Scientific High Content Screening (HCS) Revenue (US$ Million) & (2018-2023)
5.5.5 Thermo Fisher Scientific Recent Developments
6 North America
6.1 North America High Content Screening (HCS) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe High Content Screening (HCS) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific High Content Screening (HCS) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America High Content Screening (HCS) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa High Content Screening (HCS) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 High Content Screening (HCS) Market Dynamics
11.1 High Content Screening (HCS) Industry Trends
11.2 High Content Screening (HCS) Market Drivers
11.3 High Content Screening (HCS) Market Challenges
11.4 High Content Screening (HCS) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
